NCT04403958

Brief Summary

Study purpose is to compare the outcome after total wrist arthrodesis (TWA) with proximal carpal row (Proximal Row Carpectomy = PRC) as bone graft versus iliac crest cancellous bone graft. Patients with radiologically and clinically confirmed advanced osteoarthritis are randomized (1:1 computer generated sequence with random block size) to two parallel groups and will undergo either total wrist arthrodesis with PRC or TWA with iliac crest bone grafting. Baseline data is collected preoperatively and is a follow-up visits at every 6 weeks after the surgery is arranged until the wrist is fused. The primary end-point is 6 months and the primary outcome is fusion rate.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 27, 2020

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 30, 2021

Status Verified

March 1, 2021

Enrollment Period

2.3 years

First QC Date

May 21, 2020

Last Update Submit

March 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fusion rate (percent)

    6 months

Secondary Outcomes (7)

  • Pain (Visual Analogue Scale)

    6 months

  • Patient-Rated Wrist Evaluation (PRWE)

    6 months

  • Quick-Disabilities of the Arm, Shoulder and Hand (QuickDASH)

    6 months

  • Global improvement

    6 months

  • Grip strength

    6 months

  • +2 more secondary outcomes

Study Arms (2)

PRC

EXPERIMENTAL

Total wrist arthrodesis with PRC and dorsal plate

Procedure: PRC

TWA

ACTIVE COMPARATOR

Total wrist arthrodesis with dorsal plate

Procedure: TWA

Interventions

PRCPROCEDURE

Total wrist arthrodesis with dorsal plate using proximal row of the wrist as bone graft

PRC
TWAPROCEDURE

Total wrist arthrodesis with dorsal plate using iliac crest as bone graft

TWA

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 - 75
  • Symptom duration \> 3 months
  • American Society of Anaesthesiologists physical status (ASA) I-III
  • Fluent in written and spoken Finnish

You may not qualify if:

  • Age \<18 or \>75 years
  • Rheumatoid arthritis
  • Heavy smoking (\> 20 cigarettes per day)
  • Condition or medication affecting bony healing (eg diabetes mellitus with poor glycemic control, malnutrition, use of per oral corticosteroids)
  • Ulnar variance \> 1 mm
  • Wrist pain treatable with partial wrist fusion
  • Previous partial wrist fusion
  • Alcohol or drug abuse
  • Neurological condition affecting upper limb function
  • Less than 6 months after another operation of the same upper limb

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Ankylosis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Study Officials

  • Samuli Aspinen, M.D., Ph.D.

    HUS Töölö Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Samuli Aspinen, M.D., Ph.D.

CONTACT

Jorma Ryhänen, adj. prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

May 21, 2020

First Posted

May 27, 2020

Study Start

September 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2024

Last Updated

March 30, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share